Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The DEterminig Statin Intolerance for Rosuvastatin Trial

NCT06804980 is registered in ClinicalTrials.gov with Minneapolis Heart Institute Foundation as lead sponsor.

NCT NCT06804980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06804980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The DEterminig Statin Intolerance for Rosuvastatin Trial
Lead sponsor
Minneapolis Heart Institute Foundation
Phase
Phase 4
Overall status
Recruiting
Start date
February 1, 2025
Completion date
December 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

statin, statin adverse reaction, statin therapy